Cancer Treatment Results  Survival Rates Cancer Treatments / Therapy Results
Cancer
 
Search Results



Your search returned 1870 record(s).

Page 11 of 187  |  Previous Page   |  Next Page

Cancer Type:   Sort By:

This Search was Made Possible by:


  Survival: Patients: Toxicity: Treatment: Hospital: Country: Date:
101 34.3 months Epithelial ovarian cancer and fallopian tube or primary peritoneal carcinoma 4 Chemotherapy
University Medical Center Groningen Netherlands 6/2012
Treatment Details: Patients: This study involved women with epithelial ovarian cancer, Fallopian tube or primary peritoneal carcinomas. Patients were divided into two separate treatment groups. Group A cons
 
102 34.1 months Metastatic Colorectal Cancer 5 Biologic therapy
Chemotherapy
UCLA United States 6/2015
Treatment Details: Patients: This phase 2 study involved metastatic colorectal cancer patients who were divided into two separate treatment groups. Group A had 96 patients with a median age of 61 years; 64% w
 
103 34.0 months Advanced breast cancer Hormone
Rigshospitalet Denmark 6/2003
Treatment Details: Patients: This Phase III study involved 916 advanced breast cancer patients (postmenopausal) with hormone-receptor positive or unknown tumors. Patients were divided into two groups: Group 1
 
104 33.6 months Metastatic breast cancer 5 Biologic therapy
Chemotherapy
Memorial Sloan-Kettering Cancer Center United States 1/2014
Treatment Details: Patients: This phase 3 study involved female HER2-positive metastatic breast cancer patients who were divided into two separate treatment groups. Group A consisted of 181 patients and grou
 
105 33.5 months Diffuse malignant pleural mesothelioma 4 Chemotherapy
Washington Hospital Center United States 8/2012
Treatment Details: Patients: This phase 2 study involved 10 diffuse malignant pleural mesothelioma patients who had been previously treated with cytoreductive surgery and HIPEC (a specific method of chemother
 
106 33.5 months Newly diagnosed GBM 2 Immunotherapy
Radiation
Surgery
European Institute of Oncology Italy 1/2002
Treatment Details: Patients: In this study, there were a total of 37 newly diagnosed glioma patients comprised of 20 glioblastoma multiforme patients and 17 grade 3 glioma patients. Treatment: Surgery, radi
 
107 33.2 months Metastatic breast cancer 5 Chemotherapy
Centre René Gauducheau, Service Oncologie Médicale France 4/2009
Treatment Details: Patients: This phase 2 study involved 49 women with metastatic breast cancer. The median age was 53.8 years, ranging from 32.5 to 70.7 years of age. Treatment: Patients were treated w
 
108 33.2 months Platinum-sensitive ovarian cancer 4 Chemotherapy
Duke University Medical Center United States 7/2012
Treatment Details: Patients: This phase 2 study involved 74 women with recurrent, platinum-sensitive ovarian cancer. The median patient age was 64 years. Treatment: Patients were treated with a combinati
 
109 33.2 months Refractory ovarian cancer 4 Biologic therapy
Chemotherapy
University of Vermont Cancer Center United States 7/2012
Treatment Details: Patients: This phase 2 study involved 46 previously treated patients with resistant or refractory ovarian cancer. The median patient age was 64 years. Treatment: Patients were treated
 
110 33.1 months Advanced NSCLC 5 Chemotherapy
Radiation
Cancer Institute Hospital, Japanese Foundation for Cancer Research Japan 7/2009
Treatment Details: Patients: This phase 2 study involved 50 patients with advanced non-small cell lung cancer. There were 43 men and 7 women. Their median age was 63, ranging from 35 to 74 years of age.
 
Page 11 of 187  | Previous Page  | Next Page